1101 Market Street Suite 2700, Philadelphia, PA 19107

Call 215-574-0600

Philadelphia Business Lawyers: Philadelphia Biotech Firm Pays $2.75 Million Settlement

Posted on:

Philadelphia Biotechnology Company Hemispherx Biopharma has agreed to pay a $2.75 million settlement to resolve a class action lawsuit filed on behalf of shareholders. The plaintiffs allege that Hemispherx representatives made “material misrepresentations and omissions” concerning the success of clinical trials for the company’s latest drug candidate Ampligen while soliciting investments.

In 2013, the FDA rejected Hemispherx’s application to market Ampligen, a vaccine enhancer, after an advisory panel determined there was a lack of evidence to substantiate the drugs effectiveness. As a result, Hemispherx stock plunged in value by 43 percent, and the suit seeks to recover damages for investors who purchased or acquired common stock between March 14, 2012 and Dec, 2012. The proposed $2.75 million settlement cannot not be finalized until the final approval hearing scheduled to take place on July 22 at the U.S. District Court in Philadelphia.

Philadelphia business attorneys at Sidkoff, Pincus & Green P.C. are experienced in handing all aspects of business law, commercial litigation and shareholder disputes. For more information, call 215-574-0600 to schedule a consultation or contact us online.

Star
Star
Star
Star
Star

5.0 out of 5.0

Posted by a Consumer

If you are looking for an attorney who will listen to your concerns and feel that he is personally and professionally invested in your own prosperity and success as a human and business owner then look no further. I am always astonished by the level of knowledge Mr. Green has. He is confident and can deliver the right message at the right time. I trust him and his professional team to handle all my business matters.

Sidkoff, Pincus & Green bulldog emblem

Contact Us

Sidkoff, Pincus & Green bulldog emblem

Our Areas of Experience

Call Now Contact Us